[1]
N. R. Daniel, “Comparison of Efficacy and Toxicity of Gemcitabine-Cisplatin Regimen VS Gemcitabine-Capecitabine Regimen as First Line Chemotherapy in Advanced Gallbladder Carcinoma”, Asian Pac J Cancer Care, vol. 11, no. 1, pp. 43–52, Feb. 2026.